This scientific animation aims to inform investors about SAFA (anti-Serum Albumin Fab Associated) technology and its promise as an effective protein delivery platform for cancer or inflammatory disease treatments, demonstrating its adaptability and therapeutic impact. It highlights the versatility of the SAFAbody fusion protein and its key mechanism of prolonging the half-life of fused therapeutic proteins.